News | ANAVEX

View all Alzheimer's Disease Anavex2-73 Events News Releases PDD PIPELINE Press Rett Syndrome

Ladenburg Thalmann 2016 Healthcare Conference

September 20, 2016

Anavex to Participate in Mizuho Therapeutics Conference

September 14, 2016

Mizuho Therapeutics Conference

September 14, 2016

Anavex Reports Fiscal Third Quarter 2016 Financial Results

September 11, 2016

Anavex Confirms Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients Presented at AAIC 2016

Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016

Anavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer’s Patients at AAIC 2016

Anavex to Present at the Alzheimer’s Association International Conference (AAIC) 2016

Alzheimer’s Association International Conference 2016 (AAIC) – July 24, 2016

Alzheimer’s Association International Conference 2016 (AAIC) – July 27, 2016

Anavex to Present at the 2016 Rett Syndrome Symposium

Anavex Announces U.S. FDA Orphan Drug Designation for ANAVEX 2-73 for Treatment of Infantile Spasms